International Liver Congress

Meeting NewsVideo

VIDEO: Givosiran may ‘transform’ lives of patients with acute hepatic porphyria

April 20, 2019
VIENNA — In this exclusive video from the 2019 International Liver Congress, Akin Akinc, PhD, of Alnylam Pharmaceuticals, discusses results of…
Meeting NewsVideo

VIDEO: Children ‘must not be left behind’ in the fight for hepatitis elimination

April 18, 2019
CHICAGO — In this exclusive video from the International Liver Congress 2019, Marc Bulterys, MD, PhD, team leader of the Global Hepatitis…
Meeting News

Generalists, specialists must work together to ‘narrow gaps’ in HCV care cascade

April 18, 2019
VIENNA — In the face of the remaining gaps in the hepatitis C care cascade, timely screening, monitoring and linkage to care by general…
Meeting News

Prevalence of alcoholic cirrhosis rising in North American men

April 17, 2019
VIENNA — Researchers reported an increasing prevalence of alcoholic cirrhosis in a large representative Canadian population, especially among…
Meeting NewsVideo

VIDEO: Seladelpar met phase 2 alkaline phosphatase endpoint in PBC

April 17, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Marlyn J. Mayo, MD, from The University of Texas, presents…
Meeting News

Epclusa achieves best SVR rates in patients with HCV genotype 3

April 16, 2019
VIENNA — Patients with hepatitis C genotype 3 and compensated cirrhosis had higher rates of sustained virologic response after treatment with…
Meeting NewsVideo

VIDEO: Plasma shows impact of Middle Eastern diet on microbiome

April 16, 2019
VIENNA — In this exclusive video from the International Liver Congress 2019, Bajaj S. Jasmohan, MD, from the Virginia Commonwealth University…
Meeting News

Core protein inhibitor, nuc combination shows promise in HBV

April 13, 2019
VIENNA — A combination of a core protein inhibitor and nucleos(t)ide analogue therapy brought hepatitis B virus RNA and DNA below levels of…
Meeting News

Elafibranor shows anticholestatic effect in PBC

April 13, 2019
VIENNA — When patients do not fully respond to ursodeoxycholic acid, a new peroxisome proliferator-activated receptor alpha and delta agonist…
Meeting News

Emricasan reduces portal pressure in cirrhosis despite missing endpoint

April 13, 2019
VIENNA — Emricasan missed its primary endpoint of hepatic venous pressure gradient reduction in all patients with nonalcoholic…